New drug for restless legs syndrome: efficacy and safety study
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This trial tests a new drug (a calcium channel modulator) to see how well it works and how safe it is for people with moderate to severe restless legs syndrome (RLS). It may offer a new treatment option for those with typical or variant RLS.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with restless legs syndrome (RLS) by a doctor, including common or unusual forms.
- Your RLS symptoms are moderate to severe (a score of 11 or higher on a standard RLS rating scale).
- You do not have RLS caused by another condition (like severe iron deficiency, kidney problems, pregnancy, or certain drugs).
- You are not pregnant or breastfeeding, and you do not have serious heart, liver, kidney, or active mental health conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a device that sends mild electrical signals to the spinal cord to see if it can reduce severe restless legs syndrome symptoms when standard medicines haven't helped enough.
This study tests whether a spinal cord stimulator (a device that sends mild electrical pulses to the spinal cord) can help reduce severe restless legs syndrome (RLS) symptoms that have not improved with medication. If you have severe RLS, this could be a new way to find relief.
This study tests whether a spinal cord stimulator can help people with restless leg syndrome (RLS). It compares people with RLS to healthy volunteers to see if the device reduces symptoms.
This study tests whether cannabis can help people with Restless Legs Syndrome that has not improved with standard treatments. If you have RLS and other treatments haven't worked well, you may be able to join.
This trial tests if a small nerve stimulation device can safely and effectively reduce restless legs symptoms in pregnant people. If you are between 21 and 26 weeks pregnant with a confirmed diagnosis of restless legs syndrome (RLS), you may be eligible.
This study tests whether combining near-infrared light and vibration therapy can help people with type 2 diabetes who also have restless legs syndrome (an overwhelming urge to move the legs, especially at night). It aims to see if these gentle treatments can reduce the discomfort and improve your sleep.
Hear when a new Restless Leg Syndrome (RLS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.